Chronic Joint Inflammation in Dogs (Osteoarthritis, OA)
- Synonyms: Osteoarthritis, Osteoarthritis, Arthrosis deformans, degenerative joint disease
- Occurrence: common
- Location of disease: Legs
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Osteoarthritis, also known as chronic joint inflammation, is a degenerative joint disease characterized by the slow, progressive breakdown of joint cartilage and changes in joint structure. In dogs, it leads to Pain, limited mobility, and ultimately a reduced quality of life.
The most important facts at a glance
Osteoarthritis is a common joint disease in dogs that primarily affects older animals. It develops through the breakdown of joint cartilage, which acts as a buffer between the bones. Causes include age, Overweight, and genetic factors, especially in breeds such as German Shepherds and Labrador Retrievers. Injuries or misalignments such as hip dysplasia or elbow dysplasia can also contribute to osteoarthritis. Symptoms include Pain, Lameness, and limited joint mobility. The diagnosis is made through medical history, clinical examination, and imaging procedures such as X-ray. Treatment aims to relieve Pain, improve mobility, and slow the progression of the disease. Weight management, pain relievers, supplements, and physiotherapy are important components of therapy. Hydrotherapy, acupuncture, and massages can also be helpful. Prevention focuses on a balanced diet, weight control, and regular, moderate exercise. Current research is investigating genetic factors, new medications, and regenerative treatment methods such as stem cell therapies. A holistic treatment that combines veterinary medicine, physiotherapy, and nutrition could significantly improve the quality of life of dogs with osteoarthritis.
Causes
Osteoarthritis is one of the most common joint diseases in dogs and primarily affects older animals. The joint cartilage, which covers the ends of bones in a joint, acts as a buffer and allows for smooth movement. Over time or due to injuries, this cartilage can break down, leading to Inflammatory conditions and damage to the joint.
The causes of osteoarthritis in dogs are varied. One of the main causes is age, as joint cartilage naturally wears down over the years. Overweight puts additional strain on the joints and can accelerate cartilage breakdown. Genetic factors also play a role, especially in breeds prone to joint problems, such as German Shepherds or Labrador Retrievers.
Injuries or misalignments of the joints, such as hip dysplasia or elbow dysplasia, can also contribute to the development of osteoarthritis. These conditions lead to uneven loading of the joint, which damages the cartilage and promotes the degenerative process.
Symptoms
The symptoms of osteoarthritis in dogs can begin subtly and gradually worsen. A common sign is decreased activity or Reluctance to move. The dog may appear stiff after getting up and may need longer to warm up.
Other symptoms include Lameness that increases after activity, as well as Difficulty climbing stairs or jumping. The dog may also show an altered gait or feel less secure on certain surfaces. The affected joint may be swollen or tender to the touch.
In advanced cases, muscle atrophy can occur as the dog uses the affected leg less. Some dogs also show Behavioral changes such as Irritability or withdrawal due to the Pain.
Therapy
The treatment of osteoarthritis in dogs aims to relieve Pain, improve mobility, and slow the progression of osteoarthritis. An important component of treatment is weight management, as Overweight puts additional strain on the joints. A balanced diet and regular exercise can help control weight.
Pain relievers and anti-inflammatory drugs such as non-steroidal anti-inflammatory drugs (NSAID (non-steroidal anti-inflammatory drug)) are common medications for relieving Pain and Inflammatory conditions. In some cases, supplements like glucosamine and chondroitin sulfate may also be recommended to support joint health.
In addition to medication treatments, physiotherapy can be useful to improve joint mobility and strengthen the muscles. Hydrotherapy, acupuncture, and massages are other therapeutic options that can improve the dog’s quality of life.
Prognosis and follow-up care
The prognosis for dogs with osteoarthritis depends on the severity of the disease and the effectiveness of the treatment. Although osteoarthritis is not curable, early diagnosis and a comprehensive treatment plan can significantly relieve symptoms and improve the dog’s quality of life.
With appropriate treatment, many dogs can continue to lead an active and relatively pain-free life. Regular monitoring by the veterinarian and adjustments to the treatment plan are important to achieve the best possible results.
In advanced cases, however, osteoarthritis can lead to significant mobility restrictions and chronic Pain, which can severely impact the dog’s quality of life.
Prevention
The prevention of osteoarthritis in dogs focuses on minimizing risk factors and promoting a healthy lifestyle. A balanced diet and body weight control are crucial to reducing the strain on the joints.
Regular exercise in moderate amounts helps keep the joints flexible and the muscles strong. It is important to avoid activities that could increase the risk of joint injuries, such as excessive jumping or abrupt stopping and turning.
For breeds with a genetic predisposition to joint problems, regular veterinary examinations and early measures to support joint health can be helpful. Supplements that support the joints can also play a preventive role.
By paying attention to the signs of joint problems and seeking veterinary advice early, you can help slow the progression of arthritis and maintain the dog’s quality of life.
Outlook on current research
Current research on osteoarthritis in dogs focuses on various aspects of the disease, including genetic factors that contribute to the development of osteoarthritis, as well as innovative treatment approaches. Scientists are investigating the role of genetics more intensively, as certain breeds are more susceptible to osteoarthritis. By understanding the genetic predisposition, preventive measures can be developed to reduce the risk of developing osteoarthritis.
Another research focus is on discovering new treatment methods, including regenerative medicine approaches such as stem cell therapies and the use of growth factors. These methods aim to repair damaged tissue and improve the functionality of affected joints. Initial studies show promising results, but further research is necessary to confirm the long-term efficacy and safety of these treatments.
Furthermore, intensive work is being done on developing new medications that can combat Inflammatory conditions and Pain more effectively. Substances are being researched that specifically target the molecular mechanisms of inflammation and have fewer side effects than conventional non-steroidal anti-inflammatory drugs (NSAID (non-steroidal anti-inflammatory drug)). These new medications could represent a significant improvement in quality of life for dogs with osteoarthritis.
Research is also examining the role of nutrition and weight management in the prevention and treatment of osteoarthritis. Studies show that a balanced diet enriched with omega-3 fatty acids and antioxidants can have anti-inflammatory properties and thus alleviate osteoarthritis symptoms. Additionally, weight management is crucial, as Overweight puts additional strain on the joints and can worsen symptoms.
Interdisciplinary approaches that combine veterinary medicine, physiotherapy, and nutritional sciences are also being researched to develop more comprehensive treatment plans. These holistic approaches could help significantly improve the quality of life of dogs with osteoarthritis by addressing not only the symptoms but also the underlying causes of the disease.
Frequently Asked Questions (FAQs)
1. What is osteoarthritis in dogs?
2. Which dogs are most commonly affected by osteoarthritis?
3. What are the symptoms of osteoarthritis in dogs?
4. How is osteoarthritis diagnosed in dogs?
5. What treatment options are available for dogs with osteoarthritis?
6. Can dietary supplements help with osteoarthritis?
7. Is exercise good for dogs with osteoarthritis?
8. How can I help my dog with osteoarthritis at home?
9. Can osteoarthritis be cured in dogs?
10. When should I see a veterinarian if I suspect osteoarthritis in my dog?
Literature
- Innes, J. F., Lascelles, B. D. X., Bell, D., Tulloch, R., McVey, A., Northcott, C., Welbourn, M., Higgins, K., Horakova, V., & Maddox, T. W. (2025). A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis. Frontiers in Veterinary Science, 12, Article 1502218. https://doi.org/10.3389/fvets.2025.1502218
- Enomoto, M., de Castro, N., Hash, J., Thomson, A., Nakanishi-Hester, A., Perry, E., Aker, S., Haupt, E., Opperman, L., Roe, S., Cole, T., Thompson, N. A., Innes, J. F., & Lascelles, B. D. X. (2024). Prevalence of radiographic appendicular osteoarthritis and associated clinical signs in young dogs. Scientific Reports, 14, Article 2827. https://doi.org/10.1038/s41598-024-52324-9
- Cachon, T., Frykman, O., Innes, J. F., Lascelles, B. D. X., Okumura, M., Sousa, P., Staffieri, F., Steagall, P. V., & Van Ryssen, B. (2023). COAST Development Group’s international consensus guidelines for the treatment of canine osteoarthritis. Frontiers in Veterinary Science, 10, Article 1137888. https://doi.org/10.3389/fvets.2023.1137888
- Michels, G. M., Honsberger, N. A., Walters, R. R., Tena Kira, J. K. S., & Cleaver, D. M. (2023). A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody. Veterinary Anaesthesia and Analgesia, 50(5), 446–458. https://doi.org/10.1016/j.vaa.2023.06.003
- Gruen, M. E., Lascelles, B. D. X., Colleran, E., Gottlieb, A., Johnson, J., Lotsikas, P., Marcellin-Little, D., Wright, B., & AAHA Pain Management Guidelines Task Force. (2022). 2022 AAHA pain management guidelines for dogs and cats. Journal of the American Animal Hospital Association, 58(2), 55–76. https://doi.org/10.5326/JAAHA-MS-7292
- Mille, M. A., & Maixner, R. (2022). Physiotherapeutic strategies and their current evidence for canine osteoarthritis. Veterinary Sciences, 10(1), Article 2. https://doi.org/10.3390/vetsci10010002
- Corral, M. J., Moyaert, H., Fernandes, T., Escalada, M., Tena, J. K., Walters, R. R., Stegemann, M. R., & Lascelles, B. D. X. (2021). A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis. Veterinary Anaesthesia and Analgesia, 48(6), 943–955. https://doi.org/10.1016/j.vaa.2021.08.001
- Cachon, T., Frykman, O., Innes, J. F., Lascelles, B. D. X., Okumura, M., Sousa, P., Staffieri, F., Steagall, P. V., & Van Ryssen, B. (2018). Face validity of a proposed tool for staging canine osteoarthritis: Canine OsteoArthritis Staging Tool (COAST). The Veterinary Journal, 235, 1–8. https://doi.org/10.1016/j.tvjl.2018.02.017
- Innes, J. F., Lascelles, B. D. X., Bell, D., Tulloch, R., McVey, A., Northcott, C., Welbourn, M., Higgins, K., Horakova, V., & Maddox, T. W. (2025). A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis. Frontiers in Veterinary Science, 12, Article 1502218. https://doi.org/10.3389/fvets.2025.1502218
- Enomoto, M., de Castro, N., Hash, J., Thomson, A., Nakanishi-Hester, A., Perry, E., Aker, S., Haupt, E., Opperman, L., Roe, S., Cole, T., Thompson, N. A., Innes, J. F., & Lascelles, B. D. X. (2024). Prevalence of radiographic appendicular osteoarthritis and associated clinical signs in young dogs. Scientific Reports, 14, Article 2827. https://doi.org/10.1038/s41598-024-52324-9
- Cachon, T., Frykman, O., Innes, J. F., Lascelles, B. D. X., Okumura, M., Sousa, P., Staffieri, F., Steagall, P. V., & Van Ryssen, B. (2023). COAST Development Group’s international consensus guidelines for the treatment of canine osteoarthritis. Frontiers in Veterinary Science, 10, Article 1137888. https://doi.org/10.3389/fvets.2023.1137888
- Michels, G. M., Honsberger, N. A., Walters, R. R., Tena Kira, J. K. S., & Cleaver, D. M. (2023). A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody. Veterinary Anaesthesia and Analgesia, 50(5), 446–458. https://doi.org/10.1016/j.vaa.2023.06.003
- Gruen, M. E., Lascelles, B. D. X., Colleran, E., Gottlieb, A., Johnson, J., Lotsikas, P., Marcellin-Little, D., Wright, B., & AAHA Pain Management Guidelines Task Force. (2022). 2022 AAHA pain management guidelines for dogs and cats. Journal of the American Animal Hospital Association, 58(2), 55–76. https://doi.org/10.5326/JAAHA-MS-7292
- Mille, M. A., & Maixner, R. (2022). Physiotherapeutic strategies and their current evidence for canine osteoarthritis. Veterinary Sciences, 10(1), Article 2. https://doi.org/10.3390/vetsci10010002
- Corral, M. J., Moyaert, H., Fernandes, T., Escalada, M., Tena, J. K., Walters, R. R., Stegemann, M. R., & Lascelles, B. D. X. (2021). A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis. Veterinary Anaesthesia and Analgesia, 48(6), 943–955. https://doi.org/10.1016/j.vaa.2021.08.001
- Cachon, T., Frykman, O., Innes, J. F., Lascelles, B. D. X., Okumura, M., Sousa, P., Staffieri, F., Steagall, P. V., & Van Ryssen, B. (2018). Face validity of a proposed tool for staging canine osteoarthritis: Canine OsteoArthritis Staging Tool (COAST). The Veterinary Journal, 235, 1–8. https://doi.org/10.1016/j.tvjl.2018.02.017